Back
Bio-Path Holdings Vs. SELLAS Life Sciences Group Industry Stock Comparison
Sell
30
BPTH
Bio-Path Holdings
Last Price:
1.00
Seasonality Move:
9.55%
Sell
38
SLS
SELLAS Life Sciences Group
Last Price:
1.23
Seasonality Move:
8.84%
Sell
30
Bio-Path Holdings (BPTH)
is a Sell
Is Bio-Path Holdings a Buy, Sell or Hold?
- The current Bio-Path Holdings [BPTH] share price is $1.05. The Score for BPTH is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- BPTH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.26. The Score for SLS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPTH Stock Price Chart
What is Bio-Path Holdings's stock price today?
-
The Bio-Path Holdings share price today is $1.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing buying pressure, which is a positive indicator for future bullish movement.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLS is experiencing selling pressure, which indicates risk of future bearish movement.
BPTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 40.31 | Sell |
| Chaikin Money Flow: | 48035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.93 - 1.37) | Sell |
| Bollinger Bands (100): | (1.29 - 2.47) | Sell |
SLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 49.03 | Sell |
| Chaikin Money Flow: | -348060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.23 - 1.33) | Sell |
| Bollinger Bands (100): | (1.17 - 1.39) | Sell |
BPTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.99 | Buy |
| 20-day SMA: | 1.07 | Sell |
| 50-day SMA: | 1.41 | Sell |
| 200-day SMA: | 4.62 | Sell |
| 8-day EMA: | 1.01 | Buy |
| 20-day EMA: | 1.09 | Sell |
| 50-day EMA: | 1.43 | Sell |
| 200-day EMA: | 5.59 | Sell |
SLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.27 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 1.23 | Buy |
| 200-day SMA: | 1.14 | Buy |
| 8-day EMA: | 1.28 | Sell |
| 20-day EMA: | 1.27 | Sell |
| 50-day EMA: | 1.26 | Buy |
| 200-day EMA: | 1.27 | Sell |
Bio-Path Holdings Earnings Growth & BPTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $27.20 per share, and an increase next year of $2.16 per share.
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.01 per share, an increase this year of $0.53 per share, and an increase next year of $0.11 per share.
Bio-Path Holdings Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SELLAS Life Sciences Group Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||